Last reviewed · How we verify
BGB-10188
At a glance
| Generic name | BGB-10188 |
|---|---|
| Sponsor | BeiGene |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Diarrhoea
- Nausea
- Rash
- Aphthous ulcer
- Constipation
- Gastrooesophageal reflux disease
- Mouth ulceration
- Cyst
- Fatigue
- Influenza like illness
- COVID-19
- Conjunctivitis
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BGB-10188 CI brief — competitive landscape report
- BGB-10188 updates RSS · CI watch RSS
- BeiGene portfolio CI